The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
The therapeutic potential of CRF1 antagonists for anxiety
Abstract
Preclinical studies suggest that the brain corticotropin-releasing factor (CRF) systems mediate anxiety-like behavioural and somatic responses through actions at the CRF1 receptor. CRF1 antagonists block the anxiogenic-like effects of CRF and stress in animal models. Cerebrospinal fluid levels of CRF are elevated in some anxiety disorders and normalise with effective treatment, further implicating CRF systems as a therapeutic target. Prototypical CRF1 antagonists are highly lipophilic, non-competitive antagonists of peptide ligands. Modification of the chemotype and the identification of novel pharmacophores are yielding more drug-like structures with increased hydrophilicity at physiological pHs. Newer compounds exhibit improved solubility, pharmacokinetic properties, potency and efficacy. Several clinical candidates have entered Phase I/II trials. However, unmet challenges await resolution during further discovery, clinical development and therapeutic application of CRF1 antagonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Swanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953
The role of corticotropin-releasing factor in depression and anxiety disorders
Arborelius, L., Owens, M., Plotsky, P., & Nemeroff, C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600001 · Cited by 1,378
Dunn, A. J., & Berridge, C. W. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90012-d · Cited by 1,352
The economic burden of anxiety disorders in the 1990s
Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R. T., Ballenger, J. C., & Fyer, A. J. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0702 · Cited by 1,242 · cited 1×
“Anxiety disorders impair quality of life as much as other common, chronic medical conditions [3,11] and account for one-third of the financial burden of all mental illness in the US [2,13,14].”
BackgroundThe quality of care for depressive and anxiety disorders in the United States
Young, A. S., Klap, R., Sherbourne, C. D., & Wells, K. B. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.1.55 · Cited by 1,061
DSM-III-R Generalized Anxiety Disorder in the National Comorbidity Survey
Wittchen, H.-U. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950050015002 · Cited by 967 · cited 1×
“Anxiety disorders co-occur with other psychiatric [1,4-7] and non-psychiatric [8-10] medical conditions, complicating their course and severity [11,12].”
BackgroundQuality of Life in Individuals With Anxiety Disorders
Mendlowicz, M. V., & Stein, M. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.669 · Cited by 955
McWilliams, L. A., Cox, B. J., & Enns, M. W. (2003) · Pain · doi:10.1016/s0304-3959(03)00301-4 · Cited by 951
Lewis, K., Li, C., Perrin, M. H., Blount, A., Kunitake, K., Donaldson, C., Vaughan, J., Reyes, T. M., Gulyas, J., Fischer, W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121165198 · Cited by 925
Cited by
Addiction and the brain antireward system
Koob, G. F., & Le Moal, M. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.103006.093548 · Cited by 1,457
Self-citationStress dysregulation of drug reward pathways, and the transition to drug dependence
Koob, & Kreek, M. J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.05030503 · Cited by 868
Role of Corticotropin-Releasing Factor in Drug Addiction: Potential for Pharmacological Intervention
Logrip, M. L., Koob, G. F., & Zorrilla, E. P. (2011) · CNS Drugs · doi:10.2165/11587790-000000000-00000 · Cited by 476
Self-citationFunk, C. K., O'Dell, L. E., Crawford, E. F., & Koob, G. F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3096-06.2006 · Cited by 381
Self-citationPharmacological treatment of alcohol dependence: Target symptoms and target mechanisms
HEILIG, M., & EGLI, M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.001 · Cited by 377
Corticotropin-releasing factor receptors and stress-related alterations of gut motor function
Taché, Y., & Bonaz, B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30085 · Cited by 375
Funk, C. K., Zorrilla, E. P., Lee, M.-J., Rice, K. C., & Koob, G. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.063 · Cited by 276
Self-citationBreese, G. R., Sinha, R., & Heilig, M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.007 · Cited by 261
Corticotropin releasing factor: A key role in the neurobiology of addiction
Zorrilla, E. P., Logrip, M. L., & Koob, G. F. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.01.001 · Cited by 254
Self-citationGeorge, O., Ghozland, S., Azar, M. R., Cottone, P., Zorrilla, E. P., Parsons, L. H., O'Dell, L. E., Richardson, H. N., & Koob, G. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707585104 · Cited by 245
Self-citationCRF system recruitment mediates dark side of compulsive eating
Cottone, P., Sabino, V., Roberto, M., Bajo, M., Pockros, L., Frihauf, J. B., Fekete, E. M., Steardo, L., Rice, K. C., Grigoriadis, D. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908789106 · Cited by 192
“, decreased logP and logD, increased water solubility) (13).”
BackgroundSelf-citationDon’t stress about CRF: assessing the translational failures of CRF1antagonists
Spierling, S. R., & Zorrilla, E. P. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4556-2 · Cited by 170
Self-citationWang, J., Fang, Q., Liu, Z., & Lu, L. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0262-6 · Cited by 134
“Finally, a large body of preclinical studies suggests that CRF1 receptor antagonists should be considered in the treatment of anxiety and depression (Holsboer 1999; Zorrilla and Koob 2004), psychiatric disorders that are highly associated with drug addiction”
Martin-Fardon, R., Zorrilla, E. P., Ciccocioppo, R., & Weiss, F. (2010) · Brain Research · doi:10.1016/j.brainres.2009.12.027 · Cited by 112
Self-citationRegev, L., Neufeld-Cohen, A., Tsoory, M., Kuperman, Y., Getselter, D., Gil, S., & Chen, A. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.64 · Cited by 110
Regev, L., Tsoory, M., Gil, S., & Chen, A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.05.036 · Cited by 93
“Further nalyses comparing the stress-induced changes in those anxiety ndices between the groups indicate that exposure to the stressor ffected the control mice significantly more than the CeA CRF-KD ice; stress-induced change in percent of the time in the light ompartment [t (14) 2.”
BackgroundMethodGreenwell, T. N., Funk, C. K., Cottone, P., Richardson, H. N., Chen, S. A., Rice, K. C., Zorrilla, E. P., & Koob, G. F. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00142.x · Cited by 87
“Thus, antalarmin selfadministration might partly have reflected an acquired reinforcing action of antalarmin as a function of extensive drug experience, perhaps to ‘self-medicate’ the negative emotional symptoms of drug abstinence (Zorrilla & Koob 2004).”
BackgroundInfluentialSelf-citationFekete, É. M., Zhao, Y., Li, C., Sabino, V., Vale, W. W., & Zorrilla, E. P. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.078 · Cited by 70
Self-citationLowery, E. G., Sparrow, A. M., Breese, G. R., Knapp, D. J., & Thiele, T. E. (2008) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00573.x · Cited by 68
“Of the two G proteincoupled receptors, the CRF1 receptor (CRF1R) appears to be involved with the integrate emotional behavior while the CRF2 receptor (CRF2R) may modulate ingestive behaviors (Koob, 2003; Zorrilla and Koob, 2004; Zorrilla et al., 2004).”
BackgroundCRF1 and CRF2 Receptors are Required for Potentiated Startle to Contextual but not Discrete Cues
Risbrough, V. B., Geyer, M. A., Hauger, R. L., Coste, S., Stenzel-Poore, M., Wurst, W., & Holsboer, F. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.205 · Cited by 49
Vozella, V., Cruz, B., Natividad, L. A., Benvenuti, F., Cannella, N., Edwards, S., Zorrilla, E. P., Ciccocioppo, R., & Roberto, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063095 · Cited by 16
Self-citation
Metadata
- Authors
- Zorrilla, E. P., & Koob, G. F.
- Venue
- Expert Opinion on Investigational Drugs
- Publisher
- Informa UK Limited
- Published
- 2004-07
- Volume
- 13
- Issue
- 7
- Pages
- 799-828
- ISSN
- 1354-3784 (ISSN-L)
- 1744-7658
- OpenAlex
- W2062976494
- Cited by
- 176
- References
- 45
- FWCI
- 5.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.